LWM
PACB icon

Lenox Wealth Management’s Pacific Biosciences PACB Stock Holding History

Lenox Wealth Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-175
Closed – – 597
2018
Q1 		$0 Hold
175
– – ﹤0.01% 494
2017
Q4 		$0 Hold
175
– – ﹤0.01% 503
2017
Q3 		$0 Hold
175
– – ﹤0.01% 495
2017
Q2 		$1K Buy
+175
New +$706 ﹤0.01% 461

Other funds holding PACB

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Lenox Wealth Management's PACB Position: Q2 2018 in Review

Lenox Wealth Management sold out of Pacific Biosciences (PACB) in Q2 2018, closing a stake of 175 shares.

Lenox Wealth Management first reported a position in PACB in Q2 2017 and held it in 4 quarters. The position peaked at $1K in Q2 2017. 99 funds tracked by Wall St. Rank hold PACB as of Q2 2018.

  • Lenox Wealth Management reported no remaining Pacific Biosciences position as of Q2 2018 after selling out during the quarter.
  • Lenox Wealth Management sold 175 Pacific Biosciences shares in Q2 2018.
  • Lenox Wealth Management first reported a position in Pacific Biosciences in Q2 2017 and held it in 4 quarters.
  • Lenox Wealth Management's Pacific Biosciences position peaked at $1K in Q2 2017.
  • 99 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2018.

Based on Lenox Wealth Management's 13F filing for Q2 2018, filed 26 Jul 2018.